Amanote Research

Amanote Research

    RegisterSign In

Reprogramming Identifies Functionally Distinct Stages of Clonal Evolution in Myelodysplastic Syndromes

Blood - United States
doi 10.1182/blood.2018884338
Full Text
Open PDF
Abstract

Available in full text

Categories
BiochemistryImmunologyCell BiologyHematology
Date

July 11, 2019

Authors
Jasper HsuAndreea ReillyBrian J. HayesCourtnee A. CloughEric Q. KonnickBeverly Torok-StorbSuleyman GulsunerDavid WuPamela S. BeckerSiobán B. KeelJanis L. AbkowitzSergei Doulatov
Publisher

American Society of Hematology


Related search

Cytogenetic Clonal Evolution in Myelodysplastic Syndromes Is Associated With Inferior Prognosis

Cancer
Cancer ResearchOncology
2017English

Myelodysplastic Syndromes

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2011English

Myelodysplastic Syndromes

Cancer
Cancer ResearchOncology
2007English

Myelodysplastic Syndromes

2004English

Myelodysplastic Syndromes

2005English

Myelodysplastic Syndromes

2008English

Myelodysplastic Syndromes

English

The Myelodysplastic Syndromes

Emerging Cancer Therapeutics
2011English

Multilineage Dysplasia Without Increased Blasts Identifies a Poor Prognosis Subset of Myelodysplastic Syndromes

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy